Category: Finance
-
Univ. Spin-Off Develops New Cybersecurity Paradigm
A start-up enterprise from a university is developing a simplified cybersecurity infrastructure for businesses, and raised $2 million in its first funding round
-
Device Measuring Nerves on Heart Rhythm in Development
22 July 2016. A spin-off enterprise from Indiana University is creating a device to measure sympathetic nerve activity — the fight-or-flight response — in people with heart rhythm disorders. Research and development of a prototype device, by Arrhythmotech LLC in Indianapolis, is funded by a new 2-year, $1.47 million grant from National Institute of Drug…
-
Genetic Disease Biotech Gains $55M in Early Funds
A biotechnology start-up developing therapies for genetic diseases through regulation of genetic processes is raising $55 million in its first venture round.
-
Nanotech Imaging Start-Up Raises $3M in Seed Financing
A spin-off enterprise from University of California-Berkeley, developing an imaging technology with magnetic nanoparticles, is raising $3 million in funding.
-
$1 Million Challenge Seeks Child Health Solutions
A new challenge seeks technologies and solutions to reduce child mortality and improve the health of children in low-resource regions of the world.
-
Refillable HIV Prevention Implant in Development
A device implanted under the skin providing 60 days of antiretroviral drugs to prevent HIV infection is in development at Houston Methodist Research Institute.
-
American Heart Assn, Amazon Partner on Cloud Analytics
American Heart Association is offering grants for new computational tools against heart disease, with Amazon Web Services providing cloud computing resources.
-
Small Business Grant Funds R&D on New Antibiotics
A spin-off company from University of Utah received funding to develop a new antibiotic that targets the genetics of bacteria becoming resistant to antibiotics.
-
Protein Biotech Lands $51.5M in First Venture Round
A spin-off enterprise from Harvard developing therapies that block signaling proteins causing disease is raising $51.5 million its first venture funding round.
-
Animal-Free Leather Company Gains $40M in Venture Funds
A company making leather for consumer goods with tissue engineering and gene-editing from living cells is raising $40 million in its second venture round.